| 000 | 01798 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514181403.0 | ||
| 264 | 0 | _c20040511 | |
| 008 | 200405s 0 0 eng d | ||
| 022 | _a1358-863X | ||
| 024 | 7 |
_a10.1191/1358863x03vm496oa _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Royen, Niels | |
| 245 | 0 | 0 |
_aDesign of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial. _h[electronic resource] |
| 260 |
_bVascular medicine (London, England) _c2003 |
||
| 300 |
_a191-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aArterial Occlusive Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aArteries _xdrug effects |
| 650 | 0 | 4 |
_aBlood Flow Velocity _xdrug effects |
| 650 | 0 | 4 |
_aCollateral Circulation _xdrug effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aIntermittent Claudication _xdrug therapy |
| 650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
| 650 | 0 | 4 | _aResearch Design |
| 700 | 1 | _aPiek, Jan J | |
| 700 | 1 | _aLegemate, Dink A | |
| 700 | 1 | _aSchaper, Wolfgang | |
| 700 | 1 | _aOskam, Jacques | |
| 700 | 1 | _aAtasever, Bektas | |
| 700 | 1 | _aVoskuil, Michiel | |
| 700 | 1 | _aUbbink, Dirk | |
| 700 | 1 | _aSchirmer, Stephan H | |
| 700 | 1 | _aBuschmann, Ivo | |
| 700 | 1 | _aBode, Christoph | |
| 700 | 1 | _aBuschmann, Eva E | |
| 773 | 0 |
_tVascular medicine (London, England) _gvol. 8 _gno. 3 _gp. 191-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1191/1358863x03vm496oa _zAvailable from publisher's website |
| 999 |
_c14710566 _d14710566 |
||